05
2023
-
05
Microread Genetics joins hands with Thermo Fisher to build a joint innovation laboratory
On June 10, 2019, Beijing Microread Genetics Co., Ltd. (hereinafter referred to as: Microread Genetics) and Thermo Fisher Scientific (hereinafter referred to as: Thermo Fisher) signed a strategic cooperation agreement at the Beijing headquarters of Microread Genetics. Build a joint innovation laboratory. Mr. Chen Chuguang, Chairman of Microread Genetics, Ms. Liu Yuying, Project Technical Director, Mr. Peter Waterman, Vice President of Commercial Operations of Thermo Fisher China Gene and Next Generation Sequencing Business, Mr. Xu Xingguo, Senior Sales Director of Gene Science and Clinical Sequencing Business Greater China, and other relevant leaders Attended the signing ceremony.

The field of precision medicine is developing rapidly, and national policies are constantly updated. Against the background of the rapid development of precision diagnosis and treatment technology, the strategic cooperation between Microread Genetics and Thermo Fisher Scientific is undoubtedly a strong combination. Based on the application of its capillary electrophoresis technology in the field of precision medicine, Thermo Fisher will establish a joint innovation laboratory with Microread Genetics, and provide Microread Genetics with a one-stop detection platform solution including technology, products, and equipment. Jointly promote scientific research, clinical verification, academic promotion, and technical training.